A New Research Study for Patients with Alzheimer's Dementia

The ASPECT Study – an Agitation Associated with Alzheimer’s Disease Clinic Trial is a clinical research study to find out if an investigational drug called AVP-786 is safe and effective (useful) in managing agitation in adults with Alzheimer’s Dementia, when compared with placebo*.

 

Doctors in the southwest Florida area are conducting a new research study for people who struggle with Alzheimer’s Dementia. There are no costs to participate in our studies and often compensation is available for time and travel.

 

Clinical research studies are important for medical advances. Current treatments for diseases are only available because of research study volunteers.

 

To be eligible for this study, a potential participant must:

 

  • Be between the ages of 50 and 90
  • Have a diagnosis of probable Alzheimer’s disease
  • Have moderate-to-severe agitation that interferes with daily life
  • Have a caregiver who spends a minimum of 2 hours per day, 4 days a week with them and is willing and able to comply with all study procedures

 

This is not a complete list of study requirements. The study doctor will review all requirements with potential participants and their caregivers. Please contact Bradenton Research Center to learn more.